Cargando…
P1133: SUB-CUTANEOUS RITUXIMAB INDUCTION FOLLOWED BY SHORT RITUXIMAB MAINTENANCE IMPROVES PFS IN PATIENTS WITH LOW-TUMOR BURDEN FOLLICULAR LYMPHOMA. FINAL RESULTS OF FLIRT PHASE III TRIAL, A LYSA STUDY.
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430809/ http://dx.doi.org/10.1097/01.HS9.0000847400.79465.e8 |
| _version_ | 1784779879232831488 |
|---|---|
| author | Cartron, G. Bachy, E. Tilly, H. Daguindau, N. Pica, G.-M. Bijou, F. Mounier, C. Clavert, A. M. Damaj, G. L. Slama, B. Casasnovas, O. Houot, R. Bouabdallah, K. Sibon, D. Fitoussi, O. Morineau, N. Herbaux, C. Gastinne, T. Fornecker, L.-M. Haioun, C. Launay, V. Araujo, C. Benbrahim, O. Sanhes, L. Gressin, R. Gonzalez, H. Morschhauser, F. Xerri, L. Tarte, K. Pranger, D. |
| author_facet | Cartron, G. Bachy, E. Tilly, H. Daguindau, N. Pica, G.-M. Bijou, F. Mounier, C. Clavert, A. M. Damaj, G. L. Slama, B. Casasnovas, O. Houot, R. Bouabdallah, K. Sibon, D. Fitoussi, O. Morineau, N. Herbaux, C. Gastinne, T. Fornecker, L.-M. Haioun, C. Launay, V. Araujo, C. Benbrahim, O. Sanhes, L. Gressin, R. Gonzalez, H. Morschhauser, F. Xerri, L. Tarte, K. Pranger, D. |
| author_sort | Cartron, G. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430809 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94308092022-08-31 P1133: SUB-CUTANEOUS RITUXIMAB INDUCTION FOLLOWED BY SHORT RITUXIMAB MAINTENANCE IMPROVES PFS IN PATIENTS WITH LOW-TUMOR BURDEN FOLLICULAR LYMPHOMA. FINAL RESULTS OF FLIRT PHASE III TRIAL, A LYSA STUDY. Cartron, G. Bachy, E. Tilly, H. Daguindau, N. Pica, G.-M. Bijou, F. Mounier, C. Clavert, A. M. Damaj, G. L. Slama, B. Casasnovas, O. Houot, R. Bouabdallah, K. Sibon, D. Fitoussi, O. Morineau, N. Herbaux, C. Gastinne, T. Fornecker, L.-M. Haioun, C. Launay, V. Araujo, C. Benbrahim, O. Sanhes, L. Gressin, R. Gonzalez, H. Morschhauser, F. Xerri, L. Tarte, K. Pranger, D. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430809/ http://dx.doi.org/10.1097/01.HS9.0000847400.79465.e8 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Cartron, G. Bachy, E. Tilly, H. Daguindau, N. Pica, G.-M. Bijou, F. Mounier, C. Clavert, A. M. Damaj, G. L. Slama, B. Casasnovas, O. Houot, R. Bouabdallah, K. Sibon, D. Fitoussi, O. Morineau, N. Herbaux, C. Gastinne, T. Fornecker, L.-M. Haioun, C. Launay, V. Araujo, C. Benbrahim, O. Sanhes, L. Gressin, R. Gonzalez, H. Morschhauser, F. Xerri, L. Tarte, K. Pranger, D. P1133: SUB-CUTANEOUS RITUXIMAB INDUCTION FOLLOWED BY SHORT RITUXIMAB MAINTENANCE IMPROVES PFS IN PATIENTS WITH LOW-TUMOR BURDEN FOLLICULAR LYMPHOMA. FINAL RESULTS OF FLIRT PHASE III TRIAL, A LYSA STUDY. |
| title | P1133: SUB-CUTANEOUS RITUXIMAB INDUCTION FOLLOWED BY SHORT RITUXIMAB MAINTENANCE IMPROVES PFS IN PATIENTS WITH LOW-TUMOR BURDEN FOLLICULAR LYMPHOMA. FINAL RESULTS OF FLIRT PHASE III TRIAL, A LYSA STUDY. |
| title_full | P1133: SUB-CUTANEOUS RITUXIMAB INDUCTION FOLLOWED BY SHORT RITUXIMAB MAINTENANCE IMPROVES PFS IN PATIENTS WITH LOW-TUMOR BURDEN FOLLICULAR LYMPHOMA. FINAL RESULTS OF FLIRT PHASE III TRIAL, A LYSA STUDY. |
| title_fullStr | P1133: SUB-CUTANEOUS RITUXIMAB INDUCTION FOLLOWED BY SHORT RITUXIMAB MAINTENANCE IMPROVES PFS IN PATIENTS WITH LOW-TUMOR BURDEN FOLLICULAR LYMPHOMA. FINAL RESULTS OF FLIRT PHASE III TRIAL, A LYSA STUDY. |
| title_full_unstemmed | P1133: SUB-CUTANEOUS RITUXIMAB INDUCTION FOLLOWED BY SHORT RITUXIMAB MAINTENANCE IMPROVES PFS IN PATIENTS WITH LOW-TUMOR BURDEN FOLLICULAR LYMPHOMA. FINAL RESULTS OF FLIRT PHASE III TRIAL, A LYSA STUDY. |
| title_short | P1133: SUB-CUTANEOUS RITUXIMAB INDUCTION FOLLOWED BY SHORT RITUXIMAB MAINTENANCE IMPROVES PFS IN PATIENTS WITH LOW-TUMOR BURDEN FOLLICULAR LYMPHOMA. FINAL RESULTS OF FLIRT PHASE III TRIAL, A LYSA STUDY. |
| title_sort | p1133: sub-cutaneous rituximab induction followed by short rituximab maintenance improves pfs in patients with low-tumor burden follicular lymphoma. final results of flirt phase iii trial, a lysa study. |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430809/ http://dx.doi.org/10.1097/01.HS9.0000847400.79465.e8 |
| work_keys_str_mv | AT cartrong p1133subcutaneousrituximabinductionfollowedbyshortrituximabmaintenanceimprovespfsinpatientswithlowtumorburdenfollicularlymphomafinalresultsofflirtphaseiiitrialalysastudy AT bachye p1133subcutaneousrituximabinductionfollowedbyshortrituximabmaintenanceimprovespfsinpatientswithlowtumorburdenfollicularlymphomafinalresultsofflirtphaseiiitrialalysastudy AT tillyh p1133subcutaneousrituximabinductionfollowedbyshortrituximabmaintenanceimprovespfsinpatientswithlowtumorburdenfollicularlymphomafinalresultsofflirtphaseiiitrialalysastudy AT daguindaun p1133subcutaneousrituximabinductionfollowedbyshortrituximabmaintenanceimprovespfsinpatientswithlowtumorburdenfollicularlymphomafinalresultsofflirtphaseiiitrialalysastudy AT picagm p1133subcutaneousrituximabinductionfollowedbyshortrituximabmaintenanceimprovespfsinpatientswithlowtumorburdenfollicularlymphomafinalresultsofflirtphaseiiitrialalysastudy AT bijouf p1133subcutaneousrituximabinductionfollowedbyshortrituximabmaintenanceimprovespfsinpatientswithlowtumorburdenfollicularlymphomafinalresultsofflirtphaseiiitrialalysastudy AT mounierc p1133subcutaneousrituximabinductionfollowedbyshortrituximabmaintenanceimprovespfsinpatientswithlowtumorburdenfollicularlymphomafinalresultsofflirtphaseiiitrialalysastudy AT clavertam p1133subcutaneousrituximabinductionfollowedbyshortrituximabmaintenanceimprovespfsinpatientswithlowtumorburdenfollicularlymphomafinalresultsofflirtphaseiiitrialalysastudy AT damajgl p1133subcutaneousrituximabinductionfollowedbyshortrituximabmaintenanceimprovespfsinpatientswithlowtumorburdenfollicularlymphomafinalresultsofflirtphaseiiitrialalysastudy AT slamab p1133subcutaneousrituximabinductionfollowedbyshortrituximabmaintenanceimprovespfsinpatientswithlowtumorburdenfollicularlymphomafinalresultsofflirtphaseiiitrialalysastudy AT casasnovaso p1133subcutaneousrituximabinductionfollowedbyshortrituximabmaintenanceimprovespfsinpatientswithlowtumorburdenfollicularlymphomafinalresultsofflirtphaseiiitrialalysastudy AT houotr p1133subcutaneousrituximabinductionfollowedbyshortrituximabmaintenanceimprovespfsinpatientswithlowtumorburdenfollicularlymphomafinalresultsofflirtphaseiiitrialalysastudy AT bouabdallahk p1133subcutaneousrituximabinductionfollowedbyshortrituximabmaintenanceimprovespfsinpatientswithlowtumorburdenfollicularlymphomafinalresultsofflirtphaseiiitrialalysastudy AT sibond p1133subcutaneousrituximabinductionfollowedbyshortrituximabmaintenanceimprovespfsinpatientswithlowtumorburdenfollicularlymphomafinalresultsofflirtphaseiiitrialalysastudy AT fitoussio p1133subcutaneousrituximabinductionfollowedbyshortrituximabmaintenanceimprovespfsinpatientswithlowtumorburdenfollicularlymphomafinalresultsofflirtphaseiiitrialalysastudy AT morineaun p1133subcutaneousrituximabinductionfollowedbyshortrituximabmaintenanceimprovespfsinpatientswithlowtumorburdenfollicularlymphomafinalresultsofflirtphaseiiitrialalysastudy AT herbauxc p1133subcutaneousrituximabinductionfollowedbyshortrituximabmaintenanceimprovespfsinpatientswithlowtumorburdenfollicularlymphomafinalresultsofflirtphaseiiitrialalysastudy AT gastinnet p1133subcutaneousrituximabinductionfollowedbyshortrituximabmaintenanceimprovespfsinpatientswithlowtumorburdenfollicularlymphomafinalresultsofflirtphaseiiitrialalysastudy AT forneckerlm p1133subcutaneousrituximabinductionfollowedbyshortrituximabmaintenanceimprovespfsinpatientswithlowtumorburdenfollicularlymphomafinalresultsofflirtphaseiiitrialalysastudy AT haiounc p1133subcutaneousrituximabinductionfollowedbyshortrituximabmaintenanceimprovespfsinpatientswithlowtumorburdenfollicularlymphomafinalresultsofflirtphaseiiitrialalysastudy AT launayv p1133subcutaneousrituximabinductionfollowedbyshortrituximabmaintenanceimprovespfsinpatientswithlowtumorburdenfollicularlymphomafinalresultsofflirtphaseiiitrialalysastudy AT araujoc p1133subcutaneousrituximabinductionfollowedbyshortrituximabmaintenanceimprovespfsinpatientswithlowtumorburdenfollicularlymphomafinalresultsofflirtphaseiiitrialalysastudy AT benbrahimo p1133subcutaneousrituximabinductionfollowedbyshortrituximabmaintenanceimprovespfsinpatientswithlowtumorburdenfollicularlymphomafinalresultsofflirtphaseiiitrialalysastudy AT sanhesl p1133subcutaneousrituximabinductionfollowedbyshortrituximabmaintenanceimprovespfsinpatientswithlowtumorburdenfollicularlymphomafinalresultsofflirtphaseiiitrialalysastudy AT gressinr p1133subcutaneousrituximabinductionfollowedbyshortrituximabmaintenanceimprovespfsinpatientswithlowtumorburdenfollicularlymphomafinalresultsofflirtphaseiiitrialalysastudy AT gonzalezh p1133subcutaneousrituximabinductionfollowedbyshortrituximabmaintenanceimprovespfsinpatientswithlowtumorburdenfollicularlymphomafinalresultsofflirtphaseiiitrialalysastudy AT morschhauserf p1133subcutaneousrituximabinductionfollowedbyshortrituximabmaintenanceimprovespfsinpatientswithlowtumorburdenfollicularlymphomafinalresultsofflirtphaseiiitrialalysastudy AT xerril p1133subcutaneousrituximabinductionfollowedbyshortrituximabmaintenanceimprovespfsinpatientswithlowtumorburdenfollicularlymphomafinalresultsofflirtphaseiiitrialalysastudy AT tartek p1133subcutaneousrituximabinductionfollowedbyshortrituximabmaintenanceimprovespfsinpatientswithlowtumorburdenfollicularlymphomafinalresultsofflirtphaseiiitrialalysastudy AT prangerd p1133subcutaneousrituximabinductionfollowedbyshortrituximabmaintenanceimprovespfsinpatientswithlowtumorburdenfollicularlymphomafinalresultsofflirtphaseiiitrialalysastudy |